Learn

By the beginning of June 2021, almost 11% of the world’s population had received at least one dose of a coronavirus disease 2019 (COVID‐19) vaccine. This represents an extraordinary scientific and logistic achievement — in 18 months, researchers, manufacturers and governments collaborated to produce and distribute vaccines that appear effective and acceptably safe in preventing COVID‐19 and its complications.

This article reviews findings from the initial real world studies and stresses that researchers in Australia currently do not have timely access to the linked Commonwealth and state datasets needed to perform such analyses.

This MJA perspective shares more.

Details

• Explain key components of the perspective.
• List main findings.

Authors: David Henry, Mark Jones, Paulina Stehlik and Paul Glasziou

Article Type: Perspective